Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Nines

Explore full profile

Teleradiology practice company applying world-class ML and AI expertise to the field of medicine

Palo Alto, United StatesFounded 2017Health Tech & Medtech
Valuation $50–100M Last recorded · 2019
Revenue <$1M Latest reported FY
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Nines and the history behind them.

About Nines

Nines is a healthcare technology company that provides teleradiology services to hospitals and other healthcare facilities. The company's platform uses artificial intelligence to help radiologists read medical images more quickly and accurately. Nines' business model is based on a fee-per-study basis, and the company's clients include hospitals, imaging centers, and other healthcare providers.

Nines' services are designed to help healthcare facilities improve the quality of care they provide to their patients. The company's platform can help to reduce the time it takes to diagnose and treat medical conditions, and it can also help to improve the accuracy of diagnoses. Nines' services are also designed to help healthcare facilities reduce their costs.

Source: Dealroom company data

At a glance

Status
Acquired
Founded
2017
Headquarters
Palo Alto, United States
Employees
11
Open positions
None listed
Dealroom signal
74.4/100
Industry
Health
Sub-industry
Health Platform
Sector
Health Tech & Medtech, Patient Care, Telemedicine, Health Diagnostics, Tech for Patients, Hard Tech, DT and LS, science-based
Technology
Artificial Intelligence, Deep Tech, Machine Learning
Business model
SaaS
Client focus
b2b

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
ACQUISITION✓Exit Feb 2022 $0 — Sirona Medical ↗
SERIES A✓Equity / VC Nov 2019 $17M $66M Accel · 8VC · Kim Hammonds · Lori Goler —
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Financials

Revenue over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

YearRevenueGrowth
2026
2025
2024
2023
2022
2021
2020 —
Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

Nines website traffic

Latest recorded traffic for Nines is 220 monthly website visits. Nines's team declined 15.4% over the past year.

Latest monthly visits220 1-year team growth-15.4%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

6 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A5 investors entered at this stage

Other known investors1 additional known investor

  • Sirona Medical
Team profiled 6 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Nines on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Nines’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.